SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-583791
Filing Date
2016-05-09
Accepted
2016-05-09 16:05:20
Documents
59
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d162923d10q.htm 10-Q 493944
2 EX-31 d162923dex31.htm EX-31 6380
3 EX-32 d162923dex32.htm EX-32 4389
  Complete submission text file 0001193125-16-583791.txt   3148728

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mnkd-20160331.xml EX-101.INS 355550
5 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20160331.xsd EX-101.SCH 44033
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20160331_cal.xml EX-101.CAL 55527
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20160331_def.xml EX-101.DEF 279389
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20160331_lab.xml EX-101.LAB 334805
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20160331_pre.xml EX-101.PRE 323393
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 161631652
SIC: 2834 Pharmaceutical Preparations